From the ∗Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA
†Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa
‡Biostatics Shared Resource
§Department of Radiation Oncology, Winship Cancer Institute of Emory University
∥Department of Urology, Emory University
¶Department of Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
Received for publication November 14, 2022; revision accepted December 14, 2022.
Conflicts of interest and sources of funding: A.B.J. reports personal fees from Blue Earth Diagnostics for advisory board services outside the submitted work. M.G. is entitled to a royalty derived from sale of products related to the research described in this report. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The research consent forms state that he is entitled to a share of sales royalty received by Emory University from Nihon MediPhysics under that agreement. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. D.M.S. participates through the Emory University Office of Sponsored Projects in sponsored grants including those funded or partially funded by Blue Earth Diagnostics, Nihon MediPhysics, Telix Pharmaceuticals (US), Advanced Accelerator Applications, FUJIFILM Pharmaceuticals USA, and Amgen. D.M.S. also reports consultant fees outside the submitted work from Syncona, AIM Specialty Health, Global Medical Solutions Taiwan, and Progenics Pharmaceuticals. The other authors declare no competing interests. The EMPIRE-1 trial received funding from the National Institutes of Health/National Cancer Institute (R01 CA16918), Blue Earth Diagnostics, Ltd, and the Winship Cancer Institute of Emory University.
I.O.L. and C.M. contribute equally to this work and share first authorship.
Ismaheel O. Lawal ORCID 0000-0003-4273-040X
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.nuclearmed.com).
Correspondence to: Ismaheel O. Lawal, PhD, MBBS, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd NE, Atlanta, GA 30322. E-mail: [email protected].